Stockreport

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report
PDF SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to sl [Read more]